Description
Cerebrolysin is a multimodal neuropeptide mixture derived from porcine brain tissue, containing active peptide fragments and neurotrophic factors that mimic the brain’s own growth signals. It crosses the blood-brain barrier and acts through multiple pathways to support neuroregeneration, neuroprotection, and cognitive function. Approved in over 45 countries for stroke and dementia treatment, it remains one of the most clinically studied neuropeptide preparations available.